Diabetes and Ramadan: Practical guidelines.
Mohamed Hassanein,Monira Al-Arouj,Osama Hamdy,Wan Mohamad Wan Bebakar,Abdul Jabbar,Abdulrazzaq Al-Madani,Wasim Hanif,Nader Lessan,Abdul Basit,Khaled Tayeb,Mak Omar,Khalifa Abdallah,Abdulaziz Al Twaim,Mehmet Akif Buyukbese,Adel Abdel Aziz El-Sayed,Abdullah Bennakhi +15 more
Reads0
Chats0
TLDR
The IDF-DAR Practical Guidelines should enhance knowledge surrounding the issue of diabetes and Ramadan fasting, thereby empowering healthcare professionals to give the most up-to-date advice and the best possible support to their patients during Ramadan.About:
This article is published in Diabetes Research and Clinical Practice.The article was published on 2017-04-01 and is currently open access. It has received 247 citations till now.read more
Citations
More filters
Journal ArticleDOI
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
TL;DR: The present paper presents a meta-analysis of 148 cases of type 2 diabetes patients treated at the UCMS-GTB Hospital in Ahmedabad over a 12-month period from May 2013 to March 2014 that showed clear trends in disease progression and in particular in cases of high blood pressure and insulin resistance.
Journal ArticleDOI
Impact of Ramadan Diurnal Intermittent Fasting on Hypoglycemic Events in Patients With Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials and Observational Studies.
Dana Abdelrahim,Mo'ez Al-Islam E. Faris,Mohamed Hassanein,Ayman Z Shakir,Ayesha M Yusuf,Aljohara S Almeneessier,Ahmed S. BaHammam +6 more
TL;DR: In this article, the authors conducted a systematic review of available observational studies and randomized controlled trials (RCTs) for patients with Type 2 diabetes who fasted during Ramadan, with HE as the primary outcome.
Journal ArticleDOI
Diabetes, driving and fasting during Ramadan: the interplay between secular and religious law
Nazim Ghouri,Sufyan Hussain,Ruzwan Mohammed,Salem A Beshyah,Tahseen A Chowdhury,Naveed Sattar,Aziz Sheikh +6 more
TL;DR: Further research on glycemic control and management when fasting and driving, as well as a formal legal guidance on this topic, is required to safeguard healthcare professionals and the public from the potential dangers of driving with diabetes and fasting.
Journal ArticleDOI
The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care
Fatheya Alawadi,Fauzia Rashid,Alaaeldin Bashier,Elamin Abdelgadir,Maryam Al Saeed,Sona Abuelkheir,A. A. Khalifa,Fatima Al sayyah,Fawzi Bachet,Mohammed Elsayed,Khadija Abdallah,Mohamed Hassanein +11 more
TL;DR: Fasting Ramadan did not result in any significant change in biophysical and biochemical profile of patients with diabetes and CKD-stage 3 Ramadan fasting under close supervision and optimal diabetes care, was not associated with worsening of HBA1c and renal function.
Journal ArticleDOI
Attitude and safety of patients with diabetes observing the Ramadan fast.
TL;DR: Insulin therapy with or without oral agents and previous episodes of hypoglycemia before Ramadan predicted hypoglycaemia risk during Ramadan, and this was directly related to their fasting risk level.
References
More filters
Journal ArticleDOI
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
TL;DR: Clinical trials with the incretin mimetic exenatide and liraglutide show reductions in fasting and postprandial glucose concentrations, and haemoglobin A1c (HbA1c) associated with weight loss, but long-term clinical studies are needed to determine the benefits of targeting the inc retin axis for the treatment of type 2 diabetes.
Journal ArticleDOI
Impact of sleep debt on metabolic and endocrine function
TL;DR: Sleep debt has a harmful impact on carbohydrate metabolism and endocrine function similar to those seen in normal ageing and, therefore, sleep debt may increase the severity of age-related chronic disorders.
Journal ArticleDOI
Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.
TL;DR: Careful postmarketing surveillance for adverse effects, especially among the DPP4 inhibitors, and continued evaluation in longer-term studies and in clinical practice are required to determine the role of this new class of pharmacotherapies for type 2 diabetes.
Journal ArticleDOI
A Population-Based Study of Diabetes and Its Characteristics During the Fasting Month of Ramadan in 13 Countries Results of the Epidemiology of Diabetes and Ramadan 1422/2001 (EPIDIAR) study
Ibrahim Salti,Eric Bénard,Bruno Detournay,Monique Bianchi-Biscay,Corinne Le Brigand,Céline Voinet,Abdul Jabbar +6 more
TL;DR: There is a need to provide more intensive education before fasting, to disseminate guidelines, and to propose further studies assessing the impact of fasting on morbidity and mortality.
Journal ArticleDOI
Adiponectin: action, regulation and association to insulin sensitivity
TL;DR: Adiponectin in addition to possible anti‐inflammatory and anti‐atherogenic effects appears to be an insulin enhancer, with potential as a new pharmacologic treatment modality of the metabolic syndrome and type 2 diabetes.